The 5th annual Mutational Scanning Symposium will take place in Toronto on June 13-14, bringing together experts to discuss key topics in personalized medicine and variant effects. Keynote addresses by Drs. Doug Fowler and Clare Turnbull highlight the importance of interpreting genetic variants for personalized treatment.
The Seattle Flu Study's efforts to conduct COVID-19 testing were hindered by conflicting and uncoordinated regulatory actions. The study highlights the importance of a sustainable surveillance system to inform public health policy makers.
A new study published in Journal of the American Heart Association found a correlation between high cell-free DNA concentrations and markers of preeclampsia severity. Increasing amounts of circulating cell-free DNA were associated with earlier gestational age at delivery, worse systolic blood pressure, and maternal tissue injury.
A new project aims to catalog genetic variations to improve diagnosis and treatment of diseases. The Atlas of Variant Effects will focus on quantifying the functional impact of single nucleotide variants, primarily in protein-coding genes.